Evidence map›Paper›PMID 37117765›Full record

ArticleNature aging2021

RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease.

David W Craig, Elizabeth Hutchins, Ivo Violich, Eric Alsop, J Raphael Gibbs, Shawn Levy, Madison Robison, Nripesh Prasad, Tatiana Foroud, Karen L Crawford and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Whole transcriptome analysis of peripheral blood mononuclear cells from de novo and drug-naive Parkinson's disease patients.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 2 countries.

David W Craig *Institute of Translational Genomics, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0003-2040-1955
Elizabeth Hutchins *Neurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Ivo ViolichInstitute of Translational Genomics, University of Southern California, Los Angeles, CA, USA.
Eric AlsopNeurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
J Raphael GibbsLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-6985-0658
Shawn LevyHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Madison RobisonHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Nripesh PrasadHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Tatiana ForoudIndiana University, Indianapolis, IN, USA.
Karen L CrawfordMark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-3294-0828
Arthur W TogaMark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Timothy G WhitsettNeurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.
Seungchan KimCenter for Computational Systems Biology, Department of Electrical and Computer Engineering, Roy G. Perry College of Engineering, Prairie View A&M University, Prairie View, TX, USA.
Bradford CaseyThe Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.ORCID 0000-0002-2623-5997
Alyssa ReimerThe Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
Samantha J HuttenThe Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
Mark FrasierThe Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
Fabian KernChair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany.ORCID 0000-0002-8223-3750
Tobias FehlmanChair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany.ORCID 0000-0003-1967-2918
Andreas KellerChair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany.ORCID 0000-0002-5361-0895
Mark R CooksonLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Kendall Van Keuren-JensenNeurogenomics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA. kjensen@tgen.org.ORCID 0000-0001-8833-6323
Parkinson Progression Marker Initiative
Translational Genomics Research Institute · USMichael J. Fox Foundation · USUniversity of Southern California · USHudsonAlpha Institute for Biotechnology · USSaarland University · DENational Institutes of Health · USIndiana University – Purdue University Indianapolis · USPrairie View A&M University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Changes in the blood-based RNA transcriptome have the potential to inform biomarkers of Parkinson's disease (PD) progression. Here we sequenced a discovery set of whole-blood RNA species in 4,871 longitudinally collected samples from 1,570 clinically phenotyped individuals from the Parkinson's Progression Marker Initiative (PPMI) cohort. Samples were sequenced to an average of 100 million read pairs to create a high-quality transcriptome. Participants with PD in the PPMI had significantly altered RNA expression (>2,000 differentially expressed genes), including an early and persistent increase in neutrophil gene expression, with a concomitant decrease in lymphocyte cell counts. This was validated in a cohort from the Parkinson's Disease Biomarkers Program (PDBP) consisting of 1,599 participants and by alterations in immune cell subtypes. This publicly available transcriptomic dataset, coupled with available detailed clinical data, provides new insights into PD biological processes impacting whole blood and new paths for developing diagnostic and prognostic PD biomarkers.

Indexed as

Parkinson DiseaseBiomarkersDisease ProgressionHumansRNASequence Analysis, RNATranscriptomeBiomarkersRNA

Identifiers

PMID37117765
OpenAlexW3191145727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.